Gate2Brain as alumni at Caixa Impulse Validate

CaixaImpuls

On Monday 4th of October, Gate2Brain gave a talk at the Caixa Impulse Validate session. An acceleration program that provides support to early-stage biomedical research projects to help them validate their asset and define their valorization plan.

Two years ago, Gate2Brain was at this same session as an early-stage biotech being part of the program. Today, our CEO, Meritxell Teixidó, was invited alumni to explain Gate2Brain’s initial steps in its entrepreneurial journey to bring medicines beyond barriers.

An excellent session of exchange and networking brewing talent and innovative projects.

/by
You might also like
la start-up catalana una de las ganadoras del South Summit de salud en Valenciala VanguardiaGate2Brain one of the winners of the South Summit Health & Well-being
10 Top Biotech Startups to Watch in 2023StartUs10 Top Biotech Startups to Watch in 2023
Sometimes drugs need a bigger push to be more effective and reach their final destination:ExpansionThe drug booster to the brain
medicines beyond barriersG2BMedicines beyond barriers
Grit International Female Accelerator!Grit International Female AcceleratorG2B joined the Grit International Female Accelerator
EITHealth Catapult 2022eithealthGate2Brain semifinalist of EITHealth’s Catapult 2022
Gate2Brain participated on June 29 at The Milner Therapeutics Institute (MTI) Pitch Day 🗣️at the University of Cambridge, the cradle of cancer research. The MTI Pitch Day is a great initiative designed to highlight companies like us to investors, to create connections between academic entrepreneurship and investment to promote therapeutic companies. A great event that pulls together on one side academic, preclinical and research and on the other industry in an effort to push forward collaborative drug development and increase the standard of patient careGate2Brain at MIT Pitch Day at University of Cambridge
PaidhosGate2Brain wants to deliver drugs to the brain to combat intact barrier brain tumors, such as DIPG
Gate2Brain

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. We use a radically innovative peptide-based patented technology.

Where to find us

Barcelona Scientific Park
Baldiri Reixac, 4-8, Torre I
08028 Barcelona, Spain
info@gate2brain.com

Social

Gate2Brain attending BioSpain 2021BioSpain2021Pediatric Innovation Dayi4kidsPediatric Innovation Day